PMV Pharmaceuticals Announces Updated Promising Rezatapopt Monotherapy Interim Ovarian Cancer Data From PYNNACLE Phase 2 Pivotal Trial
Globe Newswire•31/08/2026•16:01 ET
0
Whiz Insights
Get started
Create a free account to read the full story.
Create a free account to read the full story.